Ujin Pharma Limited DRHP: From Chemical Distribution to Manufacturing, What the IPO Filing Reveals About Its Growth Strategy

Ujin Pharma Limited’s Main Business

Ujin Pharma Limited has been a distributor of industrial and pharmaceutical chemicals throughout India for over twenty years. The company sells a variety of products including:

• Solvents Speciality Chemicals, Inc.
• Active pharmaceutical ingredient
• Nutraceutical components

Chemical producers are focused on production, but it is distributors that provide the critical link between suppliers and industrial clients with effective sourcing, logistics, inventory control and quick delivery.

As to the DRHP of Ujin Pharma Limited, this distribution network has become one of the primary strengths of the organization.

Ujin Pharma Limited has a wide customer base

One of the most talked about aspects of the company’s operating size has been highlighted in the DRHP of The Ujin Pharma Limited.

Ujin Pharma Limited has supplied almost 8.5 lakh metric tonnes (MT) of chemical goods in the last three financial years and up to December 31, 2025.

These items were provided to more than 3,000 consumers across different industries.

The Company’s client base is broad and catering to such wide customer base eliminates dependency on few customers and indicates the Company’s well entrenched position in Indian chemical supply chain.

Business Operations Supported by Robust Supplier Network

Another crucial part of the business model is the company’s capacity to source products. Ujin Pharma Limited has built partnerships with more than 1,200 vendors, the DRHP said.

Maintaining a large supplier base can bring various operational benefits such as:

• More products in stock.
• Alternative sourcing possibilities
• Lower risk in the supply chain
• Ability to meet changing customer needs

Relationships with suppliers often become a crucial competitive advantage for distributors in the speciality chemical business.

Ujin Pharma Limited Starts Manufacturing

The report highlights perhaps the biggest strategic shift: the company’s move into manufacturing-related businesses.

Ujin Pharma Limited through its subsidiary Shiv Shakti Oxalate Private Limited has started activities in:

• Solvent recycling 
• Solvent recovery 
• Chemical processing

Companies moving into the recycling and processing sector could boost profit margins by engaging in value-added activities rather than just trade.

Why Recycling Solvents Matters

Sustainable manufacturing techniques are taking on growing importance in the chemical industry.

In industry, solvents that are recovered are often cleaned and reused, helping to limit the generation of waste and also lower the cost of manufacturing.

Read Also: IPO Process Explained in India: From Private to Public

Successful solvent recycling can deliver a number of benefits, including:

• Improved use of chemical resources
• Less influence on the environment
• Savings for industrial users
• Other income sources
• Better operating margins

According to the DRHP of Ujin Pharma Limited, this expansion could turn out to be an important element in the future growth strategy of the company.

Extension of the chemical value chain

Most companies in the chemical sector tend to focus on one part of the value chain, e.g. manufacturing, importing or distribution.

Ujin Pharma Limited seems to be adopting a more holistic approach by bolstering its presence at various points of the value chain.

It could also use its existing distribution network and integrate its manufacturing and processing processes to source, process and distribute to customers.

This integration could enhance operational efficiency and provide greater control over product quality and supply management.

But the good execution remains a significant factor that investors and industry observers undoubtedly will be watching attentively.

What investors may be watching

With Ujin Pharma Limited gearing up for its proposed IPO, market participants may want to keep in mind a few essential elements of the company:

• Expansion of the solvent recycling business
• Expansion of manufacturing capacity
• Value-added operations contribution to income
• Customer retention and acquisition
• Diversification of suppliers
• Improved margins in the years ahead

Also expected to be a major determinant of the company’s long-term profitability is its capacity to move from a largely distribution-based business to an integrated chemical corporation.

Chemical Industry Advances

Structural changes continue in India’s chemical industry, driven by rising industrial demand, pharma expansion, sustainability measures and diversification of global supply chains.

Companies that are able to leverage efficient distribution as well as manufacturing and recycling capabilities may be better positioned to capitalise on upcoming opportunities.

Ujin Pharma Limited’s task would be to scale up its modern chemical processing and solvent recovery processes while efficiently using its existing distribution network.

If successful, this plan can help it to increase its competitive position in the fast changing Indian chemical sector.

Conclusions

The Ujin Pharma Limited DRHP introduces us to a company which is rapidly evolving from being a traditional chemical distributor.

With a strong presence in the market, the company has more than two decades of experience in the industry, a client base of more than 3,000, partnerships with more than 1,200 suppliers and supply of almost 8.5 lakh MT of chemical goods during the given time.

Its recent entry into solvent recycling, recovery and chemical processing through Shiv Shakti Oxalate Private Limited is a significant strategic move to increase participation across the chemical value chain.

Execution, operational efficiency and the successful growth of its manufacturing-related companies will be key to how this change translates into better financial performance. As the IPO process moves along investors will probably weigh Ujin Pharma Limited’s proven distribution operations against its newborn manufacturing aspirations.